Results 181 to 190 of about 1,156,033 (197)

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

Journal of Hepatology, 2000
Wladimiro Jimenez, Ramon Bataller, Vicente Arroyo   +2 more
exaly  

Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis

Digestive and Liver Disease, 2018
Xiaozhong Guo, Fu-Quan Liu, Hui Lu
exaly  

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

Journal of Hepatology, 2004
Carlo Alessandria, Vicente Arroyo, Miquel Navasa   +2 more
exaly  

Terlipressin Improves Renal Function and Reverses Hepatorenal Syndrome in Patients With Systemic Inflammatory Response Syndrome

Clinical Gastroenterology and Hepatology, 2017
Florence Wong
exaly  

Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: A case–control study

Digestive and Liver Disease, 2009
A Marzano
exaly  

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis

Digestive and Liver Disease, 2017
James Fung, Tak Mao Chan, See-Ching Chan
exaly  

Terlipressin for Hepatorenal Syndrome: A Meta-Analysis of Randomized Trials

International Journal of Artificial Organs, 2009
Paul Martin, Vivek Dixit
exaly  

Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome

Digestive Diseases and Sciences, 2007
Sergio Neri, Lucia Malaguarnera, Gaetano Bertino   +2 more
exaly  

Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome

Journal of Hepatology, 1996
Joan Saló, Wladimiro Jimenez, Ramon Bataller   +2 more
exaly  

Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence

Current Medical Research and Opinion, 2019
Hui Lu, Martin Rössle, Xingshun Qi
exaly